Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Issuers

FINAL TERMS/UPSIZE: Almaviva E725m 6NC2 sr sec notes at 5.00%

HYC European Market: Deal Flow - General

Almaviva SpA (ALMAIN) EUR725m (up from EUR700m) 144A/Reg S sr sec notes due 2030 (6y). NC2 (MWC B+50bp) (50%,25%,par). Equity claw: 2y 40%. Special call: 10% per year the first 2 years at 103. NR/BB/BB+ (--/stable/stable). Via GS (B&D) physical books/BNP jt gloco/Unicredit/IMI/Banca Akros jt books, BPER as co-manager. No reg rights. List Lux. NY law. CoC at 101. The EUR315m virtual tranche A (the Acquisition Tranche) will be subject to SMR at 100 if the acquisition is not completed by 06/09/25. IPT: low-mid 5s. Price talk: 5.00%-5.25%. EUR25m upsize for GCP.

Final terms:: EUR725m at 5.00%.

Roadshow (physical meetings at GS London office and Zoom) 10/22-23 (investor call at 11am UKT 10/21). Books close 12pm UKT 10/23. Pricing 10/23 UK afternoon. UOP: finance acquisition of Iteris for $335m, redeem its existing EUR350m sr notes due 10/30/26 (callable at 101.219), GCP (EUR25m upsize for GCP). Biz: Leading provider of IT services, digital relationship management (DRM), Big Data, advanced analytics and AI in Italy and other geographies, in particular Brazil. HQ: Rome, Italy. (Acquisition announced 08/09/2024).

Investor call link: https://urldefense.com/v3/__https:/www.netroadshow.com/events/login?show=a6929ad1&confId=71333__;!!CfuTKkV6j00!qC46-taE62TAg8n9ubGBB4LB_LGUNRq1CL8VMDQtazrnhluTHurORlkUnRwMFSgm2OC5qz1CV4WKlkuStxhwCn8$.

Netroadshow link: https://urldefense.com/v3/__https:/www.netroadshow.com/nrs/home/*!/?show=c94e411b__;Iw!!O2kDR7mm-zSJ!r3AKV_4c-3ucLlxvVIny50Nhui34MKaa-t5lJgFk-dmqff-h9kRJIV9EqoDfUEzvSXv9rar-gqb7qtPAng$. Entry code: ALMAVIVA2024.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.